Arbutus Biopharma (ABUS) vs Sagimet Biosciences Series A (SGMT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Sagimet Biosciences Series A (SGMT) has outperformed Arbutus Biopharma (ABUS) over the past year, gaining 21.0% versus a gain of 0.0%. Arbutus Biopharma is the larger company by market cap ($657.6 million vs $629.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABUS | SGMT |
|---|---|---|
| Share price | $4.29 | $8.88 |
| Market cap | $657.55M | $629.67M |
| 1-day change | -4.24% | +1.37% |
| YTD return | -10.81% | +50.00% |
| 1-year return | 0.00% | +20.98% |
| 5-year return | +5.15% | — |
| P/E ratio (TTM) | 5.43 | — |
| EPS (TTM) | $0.79 | $-1.27 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.45 | $11.45 |
| 52-week low | $3.50 | $4.50 |
| Distance from 52-week high | -21.28% | -22.44% |
| Average volume | 4.68M | 1.24M |
| Shares outstanding | 153.28M | 70.34M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SGMT has outperformed ABUS by 21.0 percentage points over the past year.
ABUS vs SGMT FAQ
Which is bigger, Arbutus Biopharma or Sagimet Biosciences Series A?
Arbutus Biopharma (ABUS) is larger, with a market capitalization of $657.55M compared with $629.67M for Sagimet Biosciences Series A (SGMT).
Which stock has performed better over the past year, ABUS or SGMT?
SGMT returned +20.98% over the past 12 months, compared with 0.00% for ABUS (price return, excluding dividends). Past performance does not predict future results.
Are Arbutus Biopharma and Sagimet Biosciences Series A in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.